Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?
- PMID: 34950464
- PMCID: PMC8690133
- DOI: 10.1093/ckj/sfab087
Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?
Abstract
Background: There is an unmet need to develop safe and successful heparin-free regional anticoagulation modalities in haemodialysed patients at risk of bleeding. Whether the addition of citrate as a prefilter injection or in the dialysate itself is required to reach anticoagulation objectives when calcium-free dialysate is used as regional anticoagulation remains unclear.
Methods: In this monocentric retrospective study, we report our experience of 908 dialysis sessions performed with a calcium-free citrate-containing dialysate and calcium reinjection according to the ionic dialysance, without additional heparin.
Results: Premature termination for filter clotting occurred in 20 sessions (2.2%) and duration of session was >4.5 h in 135 (15%; maximum duration 6 h). In addition, we could investigate the citrate, calcium and acid-basis status during haemodialysis sessions performed with (citrate group, n = 20 sessions) or without (citrate-free group, n = 19 sessions) citrate in the dialysate. In 20 sessions performed in patients with underlying liver disorders and using calcium-free citrate-containing dialysate, patients' ionized calcium (iCa) and serum citrate levels were stable and remained within the normal range, respectively. Post-filter iCa was below 0.4 mmol/L in 19/20 sessions and citrate was 0.304 mmol/L (range: 0.011; 0.548). In 19 sessions that used calcium and citrate-free dialysate, post-filter iCa was 0.41 mmol/L (0.34; 0.5) and all sessions extended to 4 h or beyond.
Conclusions: Regional anticoagulation of haemodialysis with a calcium-free dialysate and calcium reinjection according to the ionic dialysance is safe. Adding citrate to the dialysate is not mandatory to prevent dialysis circuit clotting in most patients.
Keywords: calcium-free dialysate; citrate; intensive care unit; liver failure.
© The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA.
Figures
References
-
- Davenport A. What are the anticoagulation options for intermittent hemodialysis? Nat Rev Nephrol 2011; 7: 499–508 - PubMed
-
- Guillet B, Simon N, Sampol JJ et al. Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysis. Nephrol Dial Transplant 2003; 18: 2348–2353 - PubMed
-
- Gritters M, Grooteman MPC, Schoorl M et al. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 2006; 21: 153–159 - PubMed
-
- Gritters M, Borgdorff P, Grooteman MPC et al. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility? Nephrol Dial Transplant 2008; 23: 2911–2917 - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous